XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Impact of Adopting CECL (ASU 2016-13)
Stock Options
Common Stock
Common Stock
Stock Options
Retained Earnings
Retained Earnings
Impact of Adopting CECL (ASU 2016-13)
Accumulated Other Compre-hensive Income (Loss)
Balance at beginning of period (in shares) at Sep. 30, 2022       8,221,952        
Balance at beginning of period at Sep. 30, 2022 $ 218,569     $ 38,751   $ 180,535   $ (717) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 14,169         14,169    
Other comprehensive income 222             222
Repurchase of common stock (in shares)       (44,833)        
Repurchase of common stock $ (1,445)     $ (1,445)        
Exercise of stock options (in shares) 26,055     26,055        
Exercise of stock options $ 517     $ 517        
Common stock dividends (4,527)         (4,527)    
Stock-based compensation expense     $ 156   $ 156      
Balance at end of period (in shares) at Mar. 31, 2023       8,203,174        
Balance at end of period at Mar. 31, 2023 227,661     $ 37,979   190,177   (495) [1]
Balance at beginning of period (in shares) at Dec. 31, 2022       8,231,197        
Balance at beginning of period at Dec. 31, 2022 223,549     $ 38,878   185,406   (735) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 6,663         6,663    
Other comprehensive income 240             240
Repurchase of common stock (in shares)       (34,263)        
Repurchase of common stock (1,098)     $ (1,098)        
Exercise of stock options (in shares)       6,240        
Exercise of stock options 121     $ 121        
Common stock dividends (1,892)         (1,892)    
Stock-based compensation expense     78   78      
Balance at end of period (in shares) at Mar. 31, 2023       8,203,174        
Balance at end of period at Mar. 31, 2023 227,661     $ 37,979   190,177   (495) [1]
Balance at beginning of period (in shares) at Sep. 30, 2023       8,105,338        
Balance at beginning of period at Sep. 30, 2023 233,073 [2]     $ 34,771   199,386   (1,084) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 12,004         12,004    
Other comprehensive income 339             339
Repurchase of common stock (in shares)       (112,117)        
Repurchase of common stock $ (3,034)     $ (3,034)        
Exercise of stock options (in shares) 29,900     29,900        
Exercise of stock options $ 390     $ 390        
Common stock dividends (3,816)         (3,816)    
Stock-based compensation expense     211   211      
Balance at end of period (in shares) at Mar. 31, 2024       8,023,121        
Balance at end of period at Mar. 31, 2024 238,679 $ (488)   $ 32,338   207,086 $ (488) (745) [1]
Balance at beginning of period (in shares) at Dec. 31, 2023       8,120,708        
Balance at beginning of period at Dec. 31, 2023 237,369     $ 34,869   203,327   (827) [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 5,708         5,708    
Other comprehensive income 82             82
Repurchase of common stock (in shares)       (99,787)        
Repurchase of common stock (2,672)     $ (2,672)        
Exercise of stock options (in shares)       2,200        
Exercise of stock options 35     $ 35        
Common stock dividends (1,949)         (1,949)    
Stock-based compensation expense     $ 106   $ 106      
Balance at end of period (in shares) at Mar. 31, 2024       8,023,121        
Balance at end of period at Mar. 31, 2024 $ 238,679 $ (488)   $ 32,338   $ 207,086 $ (488) $ (745) [1]
[1] All amounts are net of income taxes.
[2] Derived from audited consolidated financial statements.